Drugs & Targets FDA grants Priority Review for daratumumab combination in multiple myeloma June 07, 2019Vol.45 No.23
Drugs & Targets Caris Life Sciences partners with Debiopharm International SA June 07, 2019Vol.45 No.23
Clinical Roundup Study finds link between Medicaid expansion and equity in cancer care June 07, 2019Vol.45 No.23
Clinical Roundup Long-term survival benefit shown for metastatic melanoma patients treated with Tafinlar + Mekinist June 07, 2019Vol.45 No.23
Clinical Roundup Venclexta + Gazyva combination meets primary endpoint for CLL June 07, 2019Vol.45 No.23
Clinical Roundup Pembrolizumab found safe in treating cancer patients with HIV June 07, 2019Vol.45 No.23
Clinical Roundup BMS announces first presentation of results for Opdivo + Yervoy in hepatocellular carcinoma June 07, 2019Vol.45 No.23
Clinical Roundup Lymphoma trial finds combination targeted therapy effective prior to chemotherapy June 07, 2019Vol.45 No.23
Clinical Roundup Enfortumab vedotin produced tumor response rate of 44% in bladder cancer June 07, 2019Vol.45 No.23
Clinical Roundup Researchers identify three-drug combination curbing growth in melanoma June 07, 2019Vol.45 No.23
